Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging.


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
07 2023
Historique:
received: 05 01 2023
accepted: 29 03 2023
medline: 5 7 2023
pubmed: 18 4 2023
entrez: 17 4 2023
Statut: ppublish

Résumé

Patients with known coronary artery disease (CAD) comprise a heterogenous population with varied clinical and imaging characteristics. Unsupervised machine learning can identify new risk phenotypes in an unbiased fashion. We use cluster analysis to risk-stratify patients with known CAD undergoing single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). From 37,298 patients in the REFINE SPECT registry, we identified 9221 patients with known coronary artery disease. Unsupervised machine learning was performed using clinical (23), acquisition (17), and image analysis (24) parameters from 4774 patients (internal cohort) and validated with 4447 patients (external cohort). Risk stratification for all-cause mortality was compared to stress total perfusion deficit (< 5%, 5-10%, ≥10%). Three clusters were identified, with patients in Cluster 3 having a higher body mass index, more diabetes mellitus and hypertension, and less likely to be male, have dyslipidemia, or undergo exercise stress imaging (p < 0.001 for all). In the external cohort, during median follow-up of 2.6 [0.14, 3.3] years, all-cause mortality occurred in 312 patients (7%). Cluster analysis provided better risk stratification for all-cause mortality (Cluster 3: hazard ratio (HR) 5.9, 95% confidence interval (CI) 4.0, 8.6, p < 0.001; Cluster 2: HR 3.3, 95% CI 2.5, 4.5, p < 0.001; Cluster 1, reference) compared to stress total perfusion deficit (≥10%: HR 1.9, 95% CI 1.5, 2.5 p < 0.001; < 5%: reference). Our unsupervised cluster analysis in patients with known CAD undergoing SPECT MPI identified three distinct phenotypic clusters and predicted all-cause mortality better than ischemia alone.

Identifiants

pubmed: 37067586
doi: 10.1007/s00259-023-06218-z
pii: 10.1007/s00259-023-06218-z
pmc: PMC10317876
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2656-2668

Subventions

Organisme : NHLBI NIH HHS
ID : R01HL089765
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35HL16119
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL089765
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35HL16119
Pays : United States
Organisme : British Heart Foundation
ID : FS/ICRF/20/26002
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–407. https://doi.org/10.1056/NEJMoa1915922 .
doi: 10.1056/NEJMoa1915922 pubmed: 32227755 pmcid: 7263833
Writing Committee M, Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78:e187–285. https://doi.org/10.1016/j.jacc.2021.07.053 .
doi: 10.1016/j.jacc.2021.07.053
Otaki Y, Betancur J, Sharir T, Hu LH, Gransar H, Liang JX, et al. 5-year prognostic value of quantitative versus visual MPI in subtle perfusion defects: results from REFINE SPECT. JACC Cardiovasc Imaging. 2020;13:774–85. https://doi.org/10.1016/j.jcmg.2019.02.028 .
doi: 10.1016/j.jcmg.2019.02.028 pubmed: 31202740
Slomka PJ, Betancur J, Liang JX, Otaki Y, Hu LH, Sharir T, et al. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol. 2020;27:1010–21. https://doi.org/10.1007/s12350-018-1326-4 .
doi: 10.1007/s12350-018-1326-4 pubmed: 29923104
Hu L-H, Miller RJH, Sharir T, Commandeur F, Rios R, Einstein AJ, et al. Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT. European Heart Journal - Cardiovascular Imaging. 2021;22:705–14. https://doi.org/10.1093/ehjci/jeaa134 .
doi: 10.1093/ehjci/jeaa134 pubmed: 32533137
Rios R, Miller RJH, Hu LH, Otaki Y, Singh A, Diniz M, et al. Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry. Cardiovasc Res. 2021. https://doi.org/10.1093/cvr/cvab236 .
doi: 10.1093/cvr/cvab236 pmcid: 9799052
Hu LH, Betancur J, Sharir T, Einstein AJ, Bokhari S, Fish MB, et al. Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry. Eur Heart J Cardiovasc Imaging. 2020;1:549–59. https://doi.org/10.1093/ehjci/jez177 .
doi: 10.1093/ehjci/jez177
Cho Jung S, Shrestha S, Kagiyama N, Hu L, Ghaffar Yasir A, Casaclang-Verzosa G, et al. A network-based “phenomics” approach for discovering patient subtypes from high-throughput cardiac imaging data. JACC: Cardiovascular Imaging. 2020;13:1655–70. https://doi.org/10.1016/j.jcmg.2020.02.008 .
Pezel T, Unterseeh T, Hovasse T, Asselin A, Lefevre T, Chevalier B, et al. Phenotypic clustering of patients with newly diagnosed coronary artery disease using cardiovascular magnetic resonance and coronary computed tomography angiography. Front Cardiovasc Med. 2021;8:760120. https://doi.org/10.3389/fcvm.2021.760120 .
Yoon YE, Baskaran L, Lee BC, Pandey MK, Goebel B, Lee S-E, et al. Differential progression of coronary atherosclerosis according to plaque composition: a cluster analysis of PARADIGM registry data. Scientific reports. 2021;11:17121-. https://doi.org/10.1038/s41598-021-96616-w .
Kaasenbrood L, Bhatt DL, Dorresteijn JAN, Wilson PWF, D’Agostino RB, Sr., Massaro JM, et al. Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model. J Am Heart Assoc. 2018;7:e009217. https://doi.org/10.1161/jaha.118.009217 .
Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol. 2005;12:66–77. https://doi.org/10.1016/j.nuclcard.2004.10.006 .
doi: 10.1016/j.nuclcard.2004.10.006 pubmed: 15682367
Germano G, Kavanagh PB, Slomka PJ, Van Kriekinge SD, Pollard G, Berman DS. Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach. J Nucl Cardiol. 2007;14:433–54. https://doi.org/10.1016/j.nuclcard.2007.06.008 .
doi: 10.1016/j.nuclcard.2007.06.008 pubmed: 17679052
McInnes L, Healy J, Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv. 2018.
Aggarwal CC, Hinneburg A, Keim DA. On the surprising behavior of distance metrics in high dimensional space. Database Theory—ICDT 2001: 8th International Conference London, UK, January 4–6, 2001 Proceedings 8: Springer; 2001. p. 420–34.
Bruns S, Wolterink JM, Takx RAP, van Hamersvelt RW, Sucha D, Viergever MA, et al. Deep learning from dual-energy information for whole-heart segmentation in dual-energy and single-energy non-contrast-enhanced cardiac CT. Med Phys. 2020;47:5048–60. https://doi.org/10.1002/mp.14451 .
doi: 10.1002/mp.14451 pubmed: 32786071
Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496–502.
doi: 10.1038/s41586-019-0969-x pubmed: 30787437 pmcid: 6434952
Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math. 1987;20:53–65.
doi: 10.1016/0377-0427(87)90125-7
Lê S, Josse J, Husson F. FactoMineR: An R package for multivariate analysis. J Stat Softw. 2008;25:1–18. https://doi.org/10.18637/jss.v025.i01 .
doi: 10.18637/jss.v025.i01
Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integ Peer Rev. 2016;1:1–9.
Klein E, Miller RJH,Sharir T, Einstein AJ, Fish MB, Ruddy TD, et al. Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: analysis of the REFINE SPECT registry. J Nucl Cardiol. 2020. https://doi.org/10.1007/s12350-020-02334-7
Han D, Rozanski A, Gransar H, Sharir T, Einstein AJ, Fish MB, et al. Myocardial ischemic burden and differences in prognosis among patients with and without diabetes: results from the multicenter international REFINE SPECT Registry. Diabetes Care. 2020;43:453–9. https://doi.org/10.2337/dc19-1360 .
doi: 10.2337/dc19-1360 pubmed: 31776140
Miller RJH, Sharir T, Otaki Y, Gransar H, Liang JX, Einstein AJ, et al. Quantitation of poststress change in ventricular morphology improves risk stratification. J Nucl Med. 2021;62:1582–90. https://doi.org/10.2967/jnumed.120.260141 .
doi: 10.2967/jnumed.120.260141 pubmed: 33712535 pmcid: 8612345
Miller RJH, Hu LH, Gransar H, Betancur J, Eisenberg E, Otaki Y, et al. Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registry. Eur Heart J Cardiovasc Imaging. 2020;21:567–75. https://doi.org/10.1093/ehjci/jez172 .
doi: 10.1093/ehjci/jez172 pubmed: 31302679
Wojnarski CM, Roselli EE, Idrees JJ, Zhu Y, Carnes TA, Lowry AM, et al. Machine-learning phenotypic classification of bicuspid aortopathy. J Thorac Cardiovasc Surg. 2018;155:461-9.e4.
doi: 10.1016/j.jtcvs.2017.08.123 pubmed: 29042101
Zheng Q, Delingette H, Fung K, Petersen SE, Ayache N. Pathological cluster identification by unsupervised analysis in 3,822 UK biobank cardiac MRIs. Frontiers in Cardiovascular Medicine. 2020;7. https://doi.org/10.3389/fcvm.2020.539788 .
Tang PC, Haft JW, Romano MA, Bitar A, Hasan R, Palardy M, et al. Cluster analysis of preoperative echocardiographic findings and outcomes following left ventricular device implantation. J Thorac Cardiovasc Surg. 2019;157:1851-60.e1. https://doi.org/10.1016/j.jtcvs.2018.11.099 .
doi: 10.1016/j.jtcvs.2018.11.099 pubmed: 30739772
Kwak S, Lee Y, Ko T, Yang S, Hwang I-C, Park J-B, et al. Unsupervised cluster analysis of patients with aortic stenosis reveals distinct population with different phenotypes and outcomes. Circulation: Cardiovascular Imaging. 2020;13:e009707. https://doi.org/10.1161/CIRCIMAGING.119.009707 .
Nagamine T, Gillette B, Pakhomov A, Kahoun J, Mayer H, Burghaus R, et al. Multiscale classification of heart failure phenotypes by unsupervised clustering of unstructured electronic medical record data. Sci Rep. 2020;10:21340. https://doi.org/10.1038/s41598-020-77286-6 .
doi: 10.1038/s41598-020-77286-6 pubmed: 33288774 pmcid: 7721729
Guo Q, Lu X, Gao Y, Zhang J, Yan B, Su D, et al. Cluster analysis: a new approach for identification of underlying risk factors for coronary artery disease in essential hypertensive patients. Sci Rep. 2017;7:43965. https://doi.org/10.1038/srep43965 .
doi: 10.1038/srep43965 pubmed: 28266630 pmcid: 5339815
Sharma A, Zheng Y, Ezekowitz JA, Westerhout CM, Udell JA, Goodman SG, et al. Cluster analysis of cardiovascular phenotypes in patients with type 2 diabetes and established atherosclerotic cardiovascular disease: a potential approach to precision medicine. Diabetes Care. 2022;45:204–12. https://doi.org/10.2337/dc20-2806 .
doi: 10.2337/dc20-2806 pubmed: 34716214
Bonnefous L, Kharoubi M, Bézard M, Oghina S, Le Bras F, Poullot E, et al. Assessing cardiac amyloidosis subtypes by unsupervised phenotype clustering analysis. J Am Coll Cardiol. 2021;78:2177–92. https://doi.org/10.1016/j.jacc.2021.09.858 .
doi: 10.1016/j.jacc.2021.09.858 pubmed: 34823661

Auteurs

Michelle C Williams (MC)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

Bryan P Bednarski (BP)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Konrad Pieszko (K)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Robert J H Miller (RJH)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.

Jacek Kwiecinski (J)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.
Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Aakash Shanbhag (A)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Joanna X Liang (JX)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Cathleen Huang (C)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Tali Sharir (T)

Department of Nuclear Cardiology, Assuta Medical Centers, Tel Aviv, and Ben Gurion University of the Negev, Beer Sheba, Israel.

Sharmila Dorbala (S)

Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA, USA.

Marcelo F Di Carli (MF)

Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, MA, USA.

Andrew J Einstein (AJ)

Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA.

Albert J Sinusas (AJ)

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Edward J Miller (EJ)

Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Timothy M Bateman (TM)

Cardiovascular Imaging Technologies LLC, Kansas City, MO, USA.

Mathews B Fish (MB)

Oregon Heart and Vascular Institute, Sacred Heart Medical Center, Springfield, OR, USA.

Terrence D Ruddy (TD)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.

Wanda Acampa (W)

Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.

M Timothy Hauser (MT)

Department of Nuclear Cardiology, Oklahoma Heart Hospital, Oklahoma City, OK, USA.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.

Damini Dey (D)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Daniel S Berman (DS)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA.

Piotr J Slomka (PJ)

Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Ste. Metro 203, Los Angeles, CA, 90048, USA. piotr.slomka@cshs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH